Drug Shortage Report for ANDROGEL
| Report ID | 280137 |
| Drug Identification Number | 02245345 |
| Brand name | ANDROGEL |
| Common or Proper name | TESTOSTERONE |
| Company Name | BGP PHARMA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | TESTOSTERONE |
| Strength(s) | 1% |
| Dosage form(s) | GEL |
| Route of administration | TRANSDERMAL TRANSDERMAL |
| Packaging size | 30 UNIT TRADE CA |
| ATC code | G03BA |
| ATC description | ANDROGENS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2026-03-31 |
| Actual start date | |
| Estimated end date | 2026-04-14 |
| Actual end date | |
| Shortage status | Anticipated shortage |
| Updated date | 2026-03-09 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2026-03-09 | French | Compare |
| v1 | 2026-03-09 | English | Compare |
Showing 1 to 2 of 2